Synlogic, Inc. (SYBX)
OTC Markets
Key stats Fiscal year 2025
Income statement
- Revenue
- 0 -100%
- Net income
- -1,005,000
- Operating income
- -4,008,000
- Earnings per share
- -0.08
- R&D expense
- 43,000
Growth and profitability
- Return on equity
- -8.47
- Return on assets
- -6.51
Balance sheet
- Total assets
- 15,447,000
- Shareholders' equity
- 11,863,000
- Cash and equivalents
- 14,668,000
- Current ratio
- 4.30
Cash flow and ratios
- Operating cash flow
- -4,359,000
- Free cash flow
- -4,359,000
Shareholder returns
- Shares outstanding
- 12,248,950
- Book value per share
- 0.97
Company information
- Headquarters
- Winchester, MA
- Exchange
- OTC Markets
- Fiscal year end
- 12-31
- Industry (SEC)
- Pharmaceutical Preparations
Fiscal year end: · Source: SEC EDGAR
Synlogic, Inc. trades on OTC Markets under the ticker symbol SYBX. This page brings together its price chart, company profile, key financial figures and technical indicators.